

High-quality mesenchymal stem cells for clinical application.
Umbilical cord-derived stem cells, particularly neonatal mesenchymal stem cells (MSCs), represent a highly specialized biological source within regenerative medicine, characterized by their high proliferative capacity, genetic stability, and potent paracrine activity.
Their perinatal origin gives them significant functional advantages over adult sources, including greater cell viability, lower immunogenicity, and an optimized secretory profile for modulation of the tissue microenvironment and regeneration in complex clinical contexts.
Product features

Our mesenchymal stem cells are expanded exclusively to pass 3 (P3), a stage considered optimal for preserving the balance between expansion capacity, viability, and biological function. Working at P3 allows us to obtain an adequate cell count while maintaining essential characteristics such as paracrine activity, immunomodulatory capacity, and phenotypic stability, avoiding the changes associated with prolonged in vitro expansions. Unlike lower passes, where the cell count may be limited, pass 3 offers efficient expansion without compromising biological quality. Furthermore, compared to higher passes, it helps minimize phenomena related to cellular aging, senescence, and decreased regenerative potential. This approach reflects our commitment to cell therapy based on criteria of quality, safety, and preservation of biological potency.
Quality Guarantee

Complete traceability
of each sample

Protocols aligned with international standards in cell therapy

Evaluation of viability, sterility and cell characterization prior to release
Available formats
- Vials ready for clinical use
- Different concentrations as indicated by a doctor.
- Options tailored to customized protocols
- Vial de vidrio borosilicato de 5, 10 o 20 mL con tapón de hule y sello Flip-Off de aluminio y plástico de 20 mm de diámetro




